Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart

被引:106
作者
Lim, HS [1 ]
MacFadyen, RJ [1 ]
Lip, GYH [1 ]
机构
[1] Univ Birmingham, City Hosp, Dept Med, Birmingham B18 7QH, W Midlands, England
关键词
D O I
10.1001/archinte.164.16.1737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With diabetes mellitus reaching epidemic proportions, mainly secondary to obesity, the impact of cardiovascular disease due to this combination makes it a dominant public health problem during the first quarter of the 21 st century. The complex interaction that results in diabetic heart disease is created by overlapping mechanisms. There is a propensity to develop premature,diffuse atherosclerotic coronary disease, which is associated with adverse short- and long-term morbidity and mortality. There are structural and functional abnormalities of the microvasculature, autonomic dysfunction, and intrinsic failure of myocardial contraction (so-called diabetic cardiomyopathy). These changes are amplified by arterial hypertension and kidney disease. In this review, we consider the role of the reninangiotensin-aldosterone system and how it is a crucial driver of most of the pathophysiologic mechanisms behind diabetic heart disease and why in the past 5 years blocking this system in diabetic patients has emerged as a critical therapeutic intervention.
引用
收藏
页码:1737 / 1748
页数:12
相关论文
共 150 条
[51]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[52]   DIABETIC CARDIOMYOPATHY [J].
HAMBY, RI ;
ZONERAICH, S ;
SHERMAN, L .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 229 (13) :1749-1754
[53]   Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].
Hansson, L ;
Lindholm, LH ;
Niskanen, L ;
Lanke, J ;
Hedner, T ;
Niklason, A ;
Luomanmäki, K ;
Dahlöf, B ;
de Faire, U ;
Mörlin, C ;
Karlberg, BE ;
Wester, PO ;
Björck, JE .
LANCET, 1999, 353 (9153) :611-616
[54]   Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:: principal results of the hypertension optimal treatment (HOT) randomised trial [J].
Hansson, L ;
Zanchetti, A ;
Carruthers, SG ;
Dahlöf, B ;
Elmfeldt, D ;
Julius, S ;
Ménard, J ;
Rahn, KH ;
Wedel, H ;
Westerling, S .
LANCET, 1998, 351 (9118) :1755-1762
[55]   The myocardial and vascular pathology of diabetic cardiomyopathy [J].
Hardin, NJ .
CORONARY ARTERY DISEASE, 1996, 7 (02) :99-108
[56]   EFFECTS OF METABOLIC CONTROL ON VENTRICULAR-FUNCTION IN TYPE-2 DIABETIC-PATIENTS [J].
HIRAI, J ;
UEDA, K ;
TAKEGOSHI, T ;
MABUCHI, H .
INTERNAL MEDICINE, 1992, 31 (06) :725-730
[57]   Recent progress in angiotensin II type 2 receptor research in the cardiovascular system [J].
Horiuchi, M ;
Akishita, M ;
Dzau, VJ .
HYPERTENSION, 1999, 33 (02) :613-621
[58]  
Hornig B, 1997, CIRCULATION, V95, P1115
[59]   The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women - 20 years of follow-up [J].
Hu, FB ;
Stampfer, MJ ;
Solomon, CG ;
Liu, SM ;
Willett, WC ;
Speizer, FE ;
Nathan, DM ;
Manson, JE .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (14) :1717-1723
[60]   RESIDUAL LEFT-VENTRICULAR PUMP FUNCTION AFTER ACUTE MYOCARDIAL-INFARCTION IN NIDDM PATIENTS [J].
IWASAKA, T ;
TAKAHASHI, N ;
NAKAMURA, S ;
SUGIURA, T ;
TARUMI, N ;
KIMURA, Y ;
OKUBO, N ;
TANIGUCHI, H ;
MATSUI, Y ;
INADA, M .
DIABETES CARE, 1992, 15 (11) :1522-1526